These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2857120)

  • 21. [Pathogenesis, diagnosis and therapy of ulcer disease. Therapy. 4: Pharmacological basis and therapy with H2 antagonist].
    Med Welt; 1983 Dec; 34(49):20, 22. PubMed ID: 6140616
    [No Abstract]   [Full Text] [Related]  

  • 22. Duodenal and gastric ulcer healing rates: a review.
    Legerton CW
    Am J Med; 1984 Nov; 77(5B):2-7. PubMed ID: 6095656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New drugs. H2 receptor antagonists--cimetidine and ranitidine.
    Feely J; Wormsley KG
    Br Med J (Clin Res Ed); 1983 Feb; 286(6366):695-7. PubMed ID: 6130817
    [No Abstract]   [Full Text] [Related]  

  • 25. [Josamycin combination with ranitidine in therapy of gastroduodenal ulcer: clinical efficiency].
    Maev IV; Vertkin AL; Vovk EI; Masharova AA; Bezborodnyĭ SD; Lebedeva EG
    Klin Med (Mosk); 2000; 78(3):46-50. PubMed ID: 10790966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent parotitis with H2 receptor antagonists in a patient with Sjogren's syndrome.
    Tomasko MA; Luskin AT
    Am J Med; 1988 Aug; 85(2):271. PubMed ID: 2899973
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of ranitidine and cimetidine on gastric ulcer healing and recurrence.
    Dawson J; Jain S; Cockel R
    Scand J Gastroenterol; 1984 Jul; 19(5):665-8. PubMed ID: 6089305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience.
    Bianchi Porro G
    Digestion; 1985; 32 Suppl 1():62-9. PubMed ID: 2866137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antisecretory and mucosa-protecting drugs in the acute care of peptic ulcer. Review of action principles, healing rates and side effects of approved ulcer drugs and drugs under clinical trial].
    Simon B; Müller P; Dammann HG
    Fortschr Med; 1984 Jul; 102(25-26):683-7. PubMed ID: 6147304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single blind comparative study of ranitidine and cimetidine in patients with gastric ulcer. The Belgian Peptic Ulcer Study Group.
    Gut; 1984 Sep; 25(9):999-1002. PubMed ID: 6088368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of ranitidine and cimetidine in the treatment of chronic gastric ulcer. A double-blind trial.
    Kellow JE; Barr GD; Cowen AE; Ward M; Wood L; Piper DW
    Digestion; 1983; 27(2):105-10. PubMed ID: 6313458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical review of histamine2 receptor antagonists.
    Lipsy RJ; Fennerty B; Fagan TC
    Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of the H+/K+-adenosine triphosphatase inhibitor omeprazole in peptic ulcer.
    de Bruijne JW; Snel P; Lamers CB
    Digestion; 1989; 44 Suppl 1():25-30. PubMed ID: 2691308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acid anti-secretion therapy in gastric and duodenal ulcer].
    Lattanzi A
    Clin Ter; 1981 Oct; 99(2):187-205. PubMed ID: 6119184
    [No Abstract]   [Full Text] [Related]  

  • 35. [Further development of the H2-blocker in ulcer therapy].
    Domschke S; Domschke W
    Med Klin; 1981 Jan; 76(3):68-73. PubMed ID: 6111744
    [No Abstract]   [Full Text] [Related]  

  • 36. New horizons in the pharmacologic management of peptic ulceration.
    Debas HT; Mulholland MW
    Am J Surg; 1986 Mar; 151(3):422-30. PubMed ID: 2869709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of cimetidine on serum acidic markers and Helicobacter pylori in gastric ulcer subjects.
    Lee CT; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):28-33. PubMed ID: 8820033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, double-blind comparison of famotidine with ranitidine in treatment of acute, benign gastric ulcer disease. Community-based study coupled with a patient registry.
    Brazer SR; Tyor MP; Pancotto FS; Brice RS; Garbutt JT; Wildermann NM; Harrell FE; Pryor DB; Liss CL; Root JK
    Dig Dis Sci; 1989 Jul; 34(7):1047-52. PubMed ID: 2568247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
    Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
    Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
    Ohsawa T; Hirata W; Higichi S
    Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.